{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:17:12Z","timestamp":1791919032716,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002633","name":"Association for Research on Non-Profit Organizations & Voluntary Action","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.pcd.2019.03.008","type":"journal-article","created":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T16:19:10Z","timestamp":1555777150000},"page":"61-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Levels of cytokines and GADA in type I and II diabetic patients"],"prefix":"10.1016","volume":"14","author":[{"given":"Kawa","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shnyar Hamid","family":"Qadr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridha","family":"Hassan Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosar Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heshu Sulaiman","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1084","key":"10.1016\/j.pcd.2019.03.008_bib0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/postgradmedj-2015-133281","article-title":"Pathophysiology of type I and type II diabetes mellitus: a 90-year perspective","volume":"92","author":"Zaccardi","year":"2016","journal-title":"Postgrad. Med. J."},{"issue":"Suppl. 1","key":"10.1016\/j.pcd.2019.03.008_bib0010","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"Association AD","year":"2014","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.pcd.2019.03.008_bib0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"Suppl. 1","key":"10.1016\/j.pcd.2019.03.008_bib0020","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1002\/eji.200737772","article-title":"Historical insights into cytokines","volume":"37","author":"Dinarello","year":"2007","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.pcd.2019.03.008_bib0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"issue":"5","key":"10.1016\/j.pcd.2019.03.008_bib0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000087104","article-title":"Cytokine dysregulation, inflammation and well-being","volume":"12","author":"Elenkov","year":"2005","journal-title":"Neuroimmunomodulation"},{"issue":"3","key":"10.1016\/j.pcd.2019.03.008_bib0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00125-004-1336-4","article-title":"Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications","volume":"47","author":"Donath","year":"2004","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.pcd.2019.03.008_bib0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00109-003-0450-y","article-title":"Inflammatory mediators and islet beta-cell failure: a link between type I and type II diabetes","volume":"81","author":"Donath","year":"2003","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.pcd.2019.03.008_bib0045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.pcd.2019.03.008_bib0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-065X.2012.01164.x","article-title":"The GM-CSF\/IL-3\/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling","volume":"250","author":"Broughton","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.pcd.2019.03.008_bib0055","first-page":"97","article-title":"IFN-gamma: recent advances in understanding regulation of expression, biological functions, and clinical applications","volume":"316","author":"Young","year":"2007","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.pcd.2019.03.008_bib0060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1146\/annurev.iy.11.040193.003035","article-title":"The molecular cell biology of interferon-gamma and its receptor","volume":"11","author":"Farrar","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.pcd.2019.03.008_bib0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/2251-6581-13-46","article-title":"TNF-alpha and IFN-gamma gene variation and genetic susceptibility to type I diabetes and its microangiopathic complications","volume":"13","author":"Bazzaz","year":"2014","journal-title":"J. Diabetes Metab. Disord."},{"issue":"8","key":"10.1016\/j.pcd.2019.03.008_bib0070","doi-asserted-by":"crossref","first-page":"e1003798","DOI":"10.1371\/journal.pcbi.1003798","article-title":"Possible role of interleukin-1beta in type II diabetes onset and implications for anti-inflammatory therapy strategies","volume":"10","author":"Zhao","year":"2014","journal-title":"PLoS Comput. Biol."},{"issue":"6","key":"10.1016\/j.pcd.2019.03.008_bib0075","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI200215318","article-title":"Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets","volume":"110","author":"Maedler","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.pcd.2019.03.008_bib0080","doi-asserted-by":"crossref","first-page":"59206","DOI":"10.1155\/MI\/2006\/59206","article-title":"Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children","author":"Dogan","year":"2006","journal-title":"Mediators Inflamm 2006"},{"issue":"3","key":"10.1016\/j.pcd.2019.03.008_bib0085","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1182\/blood-2006-08-043786","article-title":"Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells","volume":"110","author":"Enzler","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.pcd.2019.03.008_bib0090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/jaut.1997.0142","article-title":"Regulation of autoimmune diabetes by interleukin 3-dependent bone marrow-derived cells in NOD mice","volume":"10","author":"Ito","year":"1997","journal-title":"J. Autoimmun."},{"issue":"Pt 3","key":"10.1016\/j.pcd.2019.03.008_bib0095","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1042\/BST0360328","article-title":"Cytokine signalling in the beta-cell: a dual role for IFNgamma","volume":"36","author":"Gysemans","year":"2008","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.pcd.2019.03.008_bib0100","first-page":"1","article-title":"Association between cytokine genes polymorphisms and type I diabetes: a case-control study on Saudi population","author":"Allam","year":"2017","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.pcd.2019.03.008_bib0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fendo.2018.00032","article-title":"Islet cell associated autoantibodies and C-peptide levels in patients with diabetes and symptoms of gastroparesis","volume":"9","author":"Siraj","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"Suppl 2","key":"10.1016\/j.pcd.2019.03.008_bib0110","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.2337\/diabetes.54.suppl_2.S40","article-title":"Type I and type II diabetes: what do they have in common?","volume":"54","author":"Tuomi","year":"2005","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.pcd.2019.03.008_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0161548","article-title":"Role of pro-inflammatory cytokines and biochemical markers in the pathogenesis of type I diabetes: correlation with age and glycemic condition in diabetic human subjects","volume":"11","author":"Fatima","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pcd.2019.03.008_bib0120","doi-asserted-by":"crossref","first-page":"16275","DOI":"10.18632\/oncotarget.24527","article-title":"Autoantibodies against islet cell antigens in children with type I diabetes mellitus","volume":"9","author":"Cheng","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.pcd.2019.03.008_bib0125","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00125-012-2732-9","article-title":"Production and function of IL-12 in islets and beta cells","volume":"56","author":"Taylor-Fishwick","year":"2013","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.pcd.2019.03.008_bib0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mce.2012.03.004","article-title":"Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction","volume":"358","author":"Weaver","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.pcd.2019.03.008_bib0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.0.CO;2-V","article-title":"An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus","volume":"14","author":"Rabinovitch","year":"1998","journal-title":"Diabetes. Rev."},{"issue":"Suppl. 8","key":"10.1016\/j.pcd.2019.03.008_bib0140","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1902\/jop.2008.080246","article-title":"The role of inflammatory cytokines in diabetes and its complications","volume":"79","author":"King","year":"2008","journal-title":"J. Periodontol."},{"issue":"2","key":"10.1016\/j.pcd.2019.03.008_bib0145","first-page":"68","article-title":"Is type II diabetes a chronic inflammatory\/autoimmune disease?","volume":"15","author":"Syed","year":"2002","journal-title":"Diabetes Nutr. Metab."},{"issue":"1","key":"10.1016\/j.pcd.2019.03.008_bib0150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/diabetes.49.1.32","article-title":"Evidence of islet cell autoimmunity in elderly patients with type II diabetes","volume":"49","author":"Pietropaolo","year":"2000","journal-title":"Diabetes"}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991818304558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991818304558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:57:35Z","timestamp":1761695855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991818304558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1751991818304558"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2019.03.008","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levels of cytokines and GADA in type I and II diabetic patients","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2019.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}